Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Report ID | 153835 |
Drug Identification Number | 02401312 |
Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Common or Proper name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Company Name | HIKMA CANADA LIMITED |
Market Status | DORMANT |
Active Ingredient(s) | TAZOBACTAM PIPERACILLIN |
Strength(s) | 0.25G 2G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 2.25G VIAL |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2022-01-28 |
Estimated end date | |
Actual end date | 2022-07-21 |
Shortage status | Resolved |
Updated date | 2022-07-22 |
Company comments | To be discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-01-28 | English | Compare |
v2 | 2022-01-28 | English | Compare |
v3 | 2022-01-28 | French | Compare |
v4 | 2022-01-29 | English | Compare |
v5 | 2022-07-21 | English | Compare |
v6 | 2022-07-21 | French | Compare |
v7 | 2022-07-22 | English | Compare |
Showing 1 to 7 of 7